[70] Inotersen, a 2′-O-methoxyethyl–modified antisense oligonucleotide that inhibits hepatic production of TTR has been found in a randomized controlled trial of patients with ATTRm with polyneuropathy to improve quality of life, and modify neurological disease [71]. The gene discussed is TTR; the disease is polyneuropathy.